telisotuzumab
abbvie
['lcsm,(-blcsm)', ' vision']
luminosity- teliso-v, an adc targeting met with cytotoxic microtubular inhibitor payload--&gt; encouraging results for non-squamous, wild-type subset, especially for high met expression... concerning aes- neuropathy, vision changes, keratitis and pneumonitis #asco22 #lcsm 
Assistant Prof | Thoracic Oncology & Phase-I  @karmanoscancer | Previously @MayoCancerCare @gundersenhealth @JeffHealthAb @bpkihsofficial | Views/Tweets my own